These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11717588)

  • 1. IC14, a CD14 specific monoclonal antibody, is a potential treatment for patients with severe sepsis.
    Axtelle T; Pribble J
    J Endotoxin Res; 2001; 7(4):310-4. PubMed ID: 11717588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of clinical studies in healthy subjects and patients with severe sepsis with IC14, a CD14-specific chimeric monoclonal antibody.
    Axtelle T; Pribble J
    J Endotoxin Res; 2003; 9(6):385-9. PubMed ID: 14733726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14).
    Reinhart K; Glück T; Ligtenberg J; Tschaikowsky K; Bruining A; Bakker J; Opal S; Moldawer LL; Axtelle T; Turner T; Souza S; Pribble J
    Crit Care Med; 2004 May; 32(5):1100-8. PubMed ID: 15190957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4.
    Sprong T; van der Ley P; Steeghs L; Taw WJ; Verver-Janssen TJ; Netea MG; van der Meer JW; van Deuren M
    Eur Cytokine Netw; 2002; 13(4):411-7. PubMed ID: 12517725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans.
    Verbon A; Dekkers PE; ten Hove T; Hack CE; Pribble JP; Turner T; Souza S; Axtelle T; Hoek FJ; van Deventer SJ; van der Poll T
    J Immunol; 2001 Mar; 166(5):3599-605. PubMed ID: 11207321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
    Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
    Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.
    Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF
    Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of IC14, an anti-CD14 antibody, on plasma and cell-associated chemokines during human endotoxemia.
    Olszyna DP; Verbon A; Pribble JP; Turner T; Axtelle T; van Deventer SJ; van der Poll T
    Eur Cytokine Netw; 2003; 14(3):158-62. PubMed ID: 14656690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyanobacterial LPS antagonist (CyP)-a novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig.
    Thorgersen EB; Macagno A; Rossetti C; Mollnes TE
    Mol Immunol; 2008 Aug; 45(13):3553-7. PubMed ID: 18571239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression.
    Böcker U; Yezerskyy O; Feick P; Manigold T; Panja A; Kalina U; Herweck F; Rossol S; Singer MV
    Int J Colorectal Dis; 2003 Jan; 18(1):25-32. PubMed ID: 12458377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor--mediated process.
    Lazaron V; Leslie DB; Wasiluk KR; Dunn DL
    Surgery; 2001 Aug; 130(2):192-7. PubMed ID: 11490348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
    Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
    J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.
    Mirlashari MR; Lyberg T
    Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
    Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
    J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine production and pattern recognition receptor (PRR) expression in whole blood stimulated with pathogen-associated molecular patterns (PAMPs).
    Møller AS; Ovstebø R; Haug KB; Joø GB; Westvik AB; Kierulf P
    Cytokine; 2005 Dec; 32(6):304-15. PubMed ID: 16406558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood.
    Brekke OL; Christiansen D; Fure H; Pharo A; Fung M; Riesenfeld J; Mollnes TE
    Mol Immunol; 2008 Aug; 45(14):3804-13. PubMed ID: 18606453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation.
    Hattar K; van Bürck S; Bickenbach A; Grandel U; Maus U; Lohmeyer J; Csernok E; Hartung T; Seeger W; Grimminger F; Sibelius U
    J Leukoc Biol; 2005 Oct; 78(4):992-1000. PubMed ID: 16006536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics modulate the stimulated cytokine response to endotoxin in a human ex vivo, in vitro model.
    Ziegeler S; Raddatz A; Hoff G; Buchinger H; Bauer I; Stockhausen A; Sasse H; Sandmann I; Hörsch S; Rensing H
    Acta Anaesthesiol Scand; 2006 Oct; 50(9):1103-10. PubMed ID: 16939481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
    Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
    Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.